Eleven of these enriched pathways, such as, "Epithelial-Mesenchymal Transition", "Hypoxia", "Inflammatory Response", "KRAS Signaling Up", "p53 Pathway", "P13 AKT MTOR Signaling", "Xenobiotic Metabolism", "Apoptosis", "DNA Repair" and "Immune" were present in nineteen experimentally-validated cancer-related pathways for miRNAs57. This evidence concerns the gene AKT1 and cancer.